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Mutations in TUBGCP4 Alter Microtubule Organization
via the g-Tubulin Ring Complex in Autosomal-Recessive
Microcephaly with Chorioretinopathy
Sophie Scheidecker,1,13 Christelle Etard,2,13 Laurence Haren,3,13 Corinne Stoetzel,1 Sarah Hull,4,5
Gavin Arno,4,5 Vincent Plagnol,6 Se´verine Drunat,7 Sandrine Passemard,7 Annick Toutain,8
Cathy Obringer,1 Me´riam Koob,9 Ve´ronique Geoffroy,1 Vincent Marion,1 Uwe Stra¨hle,2 Pia Ostergaard,10
Alain Verloes,7 Andreas Merdes,3 Anthony T. Moore,4,5,11 and He´le`ne Dollfus1,12,*
We have identified TUBGCP4 variants in individuals with autosomal-recessive microcephaly and chorioretinopathy. Whole-exome
sequencing performed on one family with two affected siblings and independently on another family with one affected child revealed
compound-heterozygous mutations in TUBGCP4. Subsequent Sanger sequencing was performed on a panel of individuals from 12
French families affected by microcephaly and ophthalmic manifestations, and one other individual was identified with compound-
heterozygous mutations in TUBGCP4. One synonymous variant was common to all three families and was shown to induce exon skip-
ping; the other mutations were frameshift mutations and a deletion. TUBGCP4 encodes g-tubulin complex protein 4, a component
belonging to the g-tubulin ring complex (g-TuRC) and known to regulate the nucleation and organization of microtubules. Functional
analysis of individual fibroblasts disclosed reduced levels of the g-TuRC, altered nucleation and organization of microtubules, abnormal
nuclear shape, and aneuploidy. Moreover, zebrafish treated with morpholinos against tubgcp4were found to have reduced head volume
and eye developmental anomalies with chorioretinal dysplasia. In summary, the identification of TUBGCP4 mutations in individuals
with microcephaly and a spectrum of anomalies in eye development, particularly photoreceptor anomalies, provides evidence of an
important role for the g-TuRC in brain and eye development.A rare subset of syndromic inherited congenitalmicroceph-
alies is associated with chorioretinal dysplasia. Inheritance
has been reported to be either autosomal dominant or auto-
somal recessive. Autosomal-dominant microcephaly with
or without chorioretinopathy, lymphoedema, or mental
retardation (MCLMR [MIM 152950]), also known as Alzial
syndrome,1 has recently been attributed to mutations in
KIF11 (MIM148760), the gene encoding kinesinmotor pro-
tein Eg5, a homotetramer kinesinmotor.2 Autosomal-reces-
sive microcephaly and chorioretinopathy (MCCRP [MIM
251270]) is a very rare entity. It was reported by McKusick
in 1966 in an inbred Mennonite family and then reported
in a dozen families worldwide.3 In MCCRP, microcephaly
ranges from mild to severe and has variable impact on
cognitive performance, ranging from moderate develop-
mental delay to normal intelligence.4 The MCCRP pheno-
typic eye spectrum has also been reported as variable, but
the chorioretinopathy is a constant feature and includes
typical punched-out lesions that can severely impair vision
and occasional retinal folds that can progress to retinal1Medical Genetics Laboratory, INSERM U1112, Institute of Genetics and M
67085 Strasbourg, France; 2Institut fu¨r Toxikologie und Genetik Campus No
76344 Eggenstein-Leopoldshafen, Germany; 3Centre de Biologie du De´velop
Diseases, UCL Institute of Ophthalmology, London EC1V 9EL, UK; 5Moorfiel
WC1E 6BT, UK; 7Unite´ Fonctionnelle de Ge´ne´tique Mole´culaire, De´partement
75019 Paris, France; 8De´partement de Ge´ne´tique Me´dicale, Centre Hospita
Radiope´diatrie et Imagerie, Hoˆpitaux Universitaires de Strasbourg et Laboratoir
Universite´ de Strasbourg, Centre National de la Recherche Scientifique, 6709
Institute, St. George’s University of London, London SW17 0RE, UK; 11Ophthal
London WC1N 3JH, UK; 12Centre de Re´fe´rence National pour les Affections Ra
67091 Strasbourg, France
13These authors contributed equally to this work
*Correspondence: dollfus@unistra.fr
http://dx.doi.org/10.1016/j.ajhg.2015.02.011. 2015 by The American Societ
666 The American Journal of Human Genetics 96, 666–674, April 2, 2detachment. To date, the original MCCRP-affected family
described by McKusick has been shown to carry a read-
through variant in TUBGCP65 (tubulin, gamma complex
associated protein 6 [MIM 610053]), and more recently,
four additional individuals (in three families) with primor-
dial dwarfism, microcephaly, and retinopathy have been
reported to have TUBGCP6mutations.6
We used whole-exome sequencing to investigate fam-
ilies affected by autosomal-recessive microcephaly and
developmental eye disease fitting the MCCRP phenotype.
Subjects were recruited from genetic and ophthalmic
clinics in France and the UK. Informed consent was ob-
tained for all subjects. Ethical approval was obtained
from the local ethics committees at Hoˆpitaux Universi-
taires de Strasbourg (Strasbourg University Hospital),
Moorfields Eye Hospital, and Robert Debre´ Hospital.
Whole-exome sequencing was performed independently
in the French and the British families, and systemic and
ophthalmological examinations were performed for all
families affected by mutations in TUBGCP4 (tubulin,edicine of Alsace, Strasbourg Medical School, University of Strasbourg,
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Table 1. Summary of the Clinical and Molecular Data of Individuals with TUBGCP4 Mutations
Individuals
AII-1 AII-3 BII-2 CII-1
Mutations in TUBGCP4 c.[579dupT];[1746G>T] c.[579dupT];[1746G>T] c.[1732-?_*544þ?del];
[1746G>T]
c.[298delT];[1746G>T]
Predicted protein changes in TUBGCP4 p.[Gly194Trpfs*8];[¼] p.[Gly194Trpfs*8];[¼] p.[?];[¼] p.[Tyr100Ilefs*27];[¼]
Congenital microcephaly (OFC in SD) þ (<3) þ (<4) þ (<3) þ (<4)
Learning difficulties lower range of intellectual
ability
þ (mild) þ þ
Cerebral MRI (age at evaluation) thin corpus callosum
(3 months old)
normal limits
(3 months old)
normal limits (5 years old) normal limits
(7 months old)
Ocular Features at Last
Examination (Age)
9 Years Old 3 Years Old 5 Years Old 8 Years Old
Fundus examination
Multiple punched-out lesions þ þ þ þ
Chorioretinal fold þ  þ þ
Other retinal detachment   optic nerve hypoplasia
Microphthalmia þ þ  þ
Hyperopia R: þ1.75D
L: þ1.75D
R: þ8.25D
L: þ8D
R: þ4.5D
L: þ6.5D
R: þ9D
L: þ9D
Visual acuity (logMAR value) R: þ1
L: NL
R: þ0.6
L: þ0.6
R: þ1.2 at 1 month
L: þ1.3 at 1 month
R: þ1.3
L: þ1.3
ERG NA NA residual response no response
Abbreviations are as follows: D, diopter; L, left; NA, not available; NL, no light perception; OFC, occipital frontal circumference; and R, right.gamma complex associated protein 4 [MIM 609610]) at the
respective clinics (Table 1).
Family A consists of two affected French siblings (one
boy and one girl) and one healthy brother born to
non-consanguineous parents. The eldest affected brother
(AII-1) was referred to the Strasbourg national center for ge-
netic eye diseases (Centre de Re´fe´rence pour les Affections
Rares en Ge´ne´tique Ophtalmologique) because of chorior-
etinal dysplasia associated with congenital microcephaly.
His fundus examination revealed multiple punched-out
retinal lesions on the right and a large retinal fold on the
left, which was later complicated by total retinal detach-
ment leading to blindness in that eye at the age of 7 years
(Table 1; Figures 1A and 1B). He has normal growth and
development. He walked at 16 months and had no signif-
icant language delay. His neurological examination was
normal. Brain MRI performed in the first few months of
life revealed a thin and shortened corpus callosum but
no other anomaly except microcephaly. He had a horse-
shoe kidney. He is now 9 years old, and although he is
on the lower range of intellectual ability, he attends a
normal school. The facial gestalt shows mainly downslant-
ing palpebral fissures, large ears, large first incisors, and
mild retrognathism. His younger sister (AII-3) was diag-
nosed with microcephaly at birth (Figure 1B). She was
noted to have bilateral visual impairment and nystagmus,
and this prompted fundus examination, which showed
bilateral punched-out retinal lesions. She has normalThe Amgrowth. She walked at 18 months and has no significant
language delay. Further neurological examination was
normal. Her MRI scan was technically poor but showed
no major anomaly (Table 1). Morphological examination
showed the same features as in her brother.
We performed whole-exome sequencing for the two
affected siblings (AII-1 and AII-3), the healthy brother
(AII-2), and the healthy mother (AI-2). Exons of DNA sam-
ples were captured with in-solution enrichment method-
ology (Agilent SureSelect All Exon XT2 50 Mb Kit) and
sequenced with an Illumina HiSeq 2500 instrument, re-
sulting in a coverage of at least ten reads for more than
93% of the targeted exomes. SNPs and indels were called
with the Genome Analysis Toolkit v.2.5.2, and 60,041–
62,197 genetic variants per proband were identified (Tables
S1 and S4). Identification of the disease-causing variants
was performed with the VaRank program for the annota-
tion, ranking, and filtering of genetic variants. Very strin-
gent criteria were used for excluding the following
non-pathogenic variants in particular: (1) variants repre-
sented with an allele frequency of more than 1% in dbSNP
138 or the NHLBI Exome Sequencing Project Exome
Variant Server (EVS), (2) variants found at the homozygous
state or more than once at the heterozygous state in 48
control exomes, (3) variants in the 50 or 30 UTR, (4) variants
with intronic locations and no prediction of local splice
effect, and (5) synonymous variants without prediction
of local splice effect. Finally, we identified three candidateserican Journal of Human Genetics 96, 666–674, April 2, 2015 667
Figure 1. Clinical Presentation and Pedigrees of Families Affected by Microcephaly and Chorioretinal Dysplasia and TUBGCP4
Mutations
(A) Fundus photographs of individual AII-1 show, on the right side, multiple punched-out retinal lesions (1) and widespread pigmentary
changes and, on the left side, a large retinal fold emerging from the optic disc (2) and a nasal extension (3) complicated a few months
later by total retinal detachment (not shown). Fundus photographs of individual BII-2 showmultiple areas of chorioretinal atrophy with
punched-out lesions, absence of retinal vessels, and optic nerve remnants (4 and 5).
(B) Head circumference of individuals AII-1, AII-3, and CII-1 shows congenital microcephaly (affected individuals’ curves are in red, and
the black curves show the SD).
(C) Schematic representation of TUBGCP4: this gene extends over 38 kb in chromosomal region 15q15.3 and contains 18 exons (vertical
gray hatches). The positions of the start codon (ATG) and the stop codon (TGA) are indicated. The mutations detected in this study
occur in exons 3, 7, and 16. The deletion includes exons 16–18. The segregation analysis confirmed autosomal-recessive inheritance
(affected individuals are blackened). In the family A pedigree, affected individuals (AII-1 and AII-3) harbor compound-heterozygous mu-
tations c.[578_579insT];[1746G>T] in TUBGCP4. In the family B pedigree, the affected girl (BII-2) harbors compound-heterozygous
mutations c.[298delT];[1746G>T]. In the family C pedigree, the affected girl (CII-1) harbors compound-heterozygous mutations
c.[1746G>T];[1732-?_*544þ?del]. NA indicates not available.genes (TRPM2 [transient receptor potential cation channel,
subfamily M, member 2 (MIM 603749)], ERICH6B
[glutamate-rich 6B], and TUBGCP4) with compound-het-
erozygous variants present only in the affected offspring
and with one heterozygous variant found in the
mother (filtering by segregation). TRPM2 was excluded
because the two variants (c.3653C>A [p.Ala1218Glu]
[RefSeq accession number NM_003307.3] and c.1762C>T
[p.Leu588Phe] [RefSeq NM_003307.3]) were not predicted
to be pathogenic according to SIFT7 and PolyPhen-2.8668 The American Journal of Human Genetics 96, 666–674, April 2, 2Moreover, this gene was implicated in inflammation rather
than developmental disease according to the animal
model.9 In the second gene, ERICH6B, one variant was at
the end of six reads and was probably an artifact, and the
second variant was in a GGGG repeat and was probably
not pathogenic. We then focused the subsequent study
on compound-heterozygous variants in TUBGCP4: a
heterozygous frameshift (c.579dupT [p.Gly194Trpfs*8]
[RefSeq NM_014444.2]) and a heterozygous synony-
mous variant with a strongly activated cryptic acceptor015
(c.1746G>T [p.¼] [RefSeq NM_014444.2]). Bothmutations
are rare—their frequencies in the NHLBI EVS and ExAC are
1/11,597 and 14/120,608 (MAF¼ 0.0001161), respectively,
for c.579dupT and 6/12,096 and 24/66,538 (MAF ¼
0.00036), respectively, for c.1746G>T (Figure 1C).
Family B consists of one affected child (BII-2) and one
healthy sister born to non-consanguineous parents from
the UK. The girl was born at 36 weeks of gestation after
a normal delivery. Intrauterine growth retardation was
noticed. At 6 weeks of age, she was noticed to have micro-
cephaly with nystagmus and poor vision. MRI scans per-
formed when she was 3 months and 5 years of age were
within normal limits. Her general health was good, but she
was developmentally delayed and had learning difficulties.
Pattern visual evoked potentials indicated rudimentary to
poor vision levels for both eyes. Full-field electroretinog-
raphy (ERG) was markedly attenuated with a small residual
response, indicating severe rod and cone dysfunction.
Fundus examination showed multiple round areas of cho-
rioretinal atrophy (Figure 1A), and fluorescein angiogram
showed absent retinal circulation but the presence of
choroidal circulation. Vision remained very poor on
follow-up (Table 1). For exome sequencing purposes, the
DNA was analyzed by high-throughput sequencing (exon
capture: Illumina TruSeq or Nextera Kit; sequencing:
IlluminaHiSeq2000) at AROSApplied Biotechnology. Reads
were aligned to the hg19 human reference sequence (UCSC
Genome Browser) with Novoalign (Novocraft) v.2.05. The
ANNOVAR tool10 was used to annotate SNPs and small
indels. Analysis of copy-number variation was performed
with ExomeDepth11 on the basis of read-depth data. We
identified the two compound-heterozygous variants in
TUBGCP4: c.1746G>T and c.1732-?_*544þ?del (RefSeq
NM_014444.2; corresponding to a deletion of exons 16–18,
including at least 544 nucleotides of the 30 UTR) (Figure 1C).
To explore additional cases of autosomal-recessive
MCCRP, we performed Sanger sequencing of TUBGCP4
(primers used are detailed in Table S2) on a cohort of 12
additional French microcephaly-affected families reported
to also have eye anomalies (these families were included
in the National Programme Hospitalier de Recherche
Clinique study carried out at the Robert Debre´ Hospital
in Paris). In one French family (family C) with one affected
girl (CII-1), we identified two mutations in TUBGCP4:
c.298delT (p.Tyr100Ilefs*27) (RefSeq NM_014444.2) and
again the c.1746G>T synonymous mutation (Figure 1C).
The individual had been referred by the University Hospi-
tal of Tours and presented with congenital microcephaly
(Figure 1B). Her height was unremarkable, but she had
been progressively overweight (þ3 SDs) since the age of 2
years. She walked at 16 months, and her speech was de-
layed. The presence of nystagmus prompted an ocular
examination, which revealed numerous punched-out cho-
rioretinal lesions throughout the retina, optic nerve hypo-
plasia, and absence of retinal vessels (Table 1; Figure 1A).
ERG showed absent responses when she was 6 months
and 8 months of age.The AmThus, we report herein on three families who are affected
by autosomal-recessive MCCRP and carry compound-het-
erozygousTUBGCP4mutations. Theyall share the samesyn-
onymous variant (c.1746G>T), and each has an additional
severe mutation (one of two frameshifts [c.579dupT
(p.Gly194Trpfs*8) and c.298delT (p.Tyr100Ilefs*27)] or one
three-exon deletion).
The synonymous c.1746G>T mutation is predicted to
have a local splice effect as a strong cryptic acceptor site
according to Alamut (Interactive Biosoftware). We per-
formed reverse transcription of mRNA obtained from
skin fibroblasts of individual AII-1 and from a healthy un-
related control individual, and we then sequenced the full-
length cDNA from both individuals. We obtained three
PCR products after amplification of the cDNA of AII-1
and only one PCR product for the control individual
(Figure S1). From the cDNA of AII-1, the shortest product
(found only in the affected individual) was sequenced
and showed exon 16 skipping. The affected individual’s
two remaining PCR products, found in the same position
as in the control individual (a 1-bp difference), showed
on sequencing the maternal allele carrying c.579dupT
and the paternal allele carrying c.1746G>T. Together,
the presence of three cDNA products—maternal cDNA,
paternal cDNA without exon 16, and paternal cDNA
with functional exon 16—suggests that the splicing defect
results in alternative exon 16 skipping and thus generates
a population of unstable mRNA (without exon 16) and
residual production of non-spliced cDNA containing
exon 16. Moreover, qPCR on cDNA extracted from skin
fibroblasts revealed that the amount of TUBGCP4 was
drastically lower in the affected individual than in the
control individual (Figure S1).
We then examined the cellular consequences of the mu-
tations in fibroblasts derived from a skin biopsy in the in-
dex individual, AII-1. Fibroblasts were grown at 37C
in Dulbecco’s modified Eagle’s medium containing 15%
fetal calf serum. For immunofluorescence, cells grown on
coverslips were fixed in methanol at 20C and processed
according to conventional protocols. Fluorescence micro-
scopy was performed on a microscope (Axiovert, Carl
Zeiss) with a 633 objective (1.4 numerical aperture). Im-
ages were acquired with a camera (Axiocam MRm, Carl
Zeiss) and processed with Adobe Photoshop. For immuno-
blotting, 40 mg of cell extracts was submitted to SDS-PAGE
and immunoblotted with the Odyssey imaging system (Li-
Cor Biosciences). For visualization of g-tubulin ring com-
plexes (g-TuRCs), extracts were submitted to sucrose
gradient sedimentation as described in Haren et al.12
Quantification of protein intensities was performed with
Odyssey software. Cells grown on fibronectin-coated cov-
erslips were transferred on ice for 45min and then into pre-
warmed medium at 25C. At the indicated time points,
coverslips were transferred into permeabilization buffer
(60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM
MgCl2, 0.1% saponin, pH 6.9) for 40 s before methanol
fixation.erican Journal of Human Genetics 96, 666–674, April 2, 2015 669
Figure 2. Fibroblasts from Individual AII-1 Have Reduced Amounts of GCP4 and g-TuRCs and Show Aneuploidy
(A) Immunoblot shows lower GCP4 levels in the fibroblasts from individual AII-1 than in control fibroblasts. Antibodies against the
N-terminal domain (Ab:Nt) or a C-terminal peptide (Ab:Ct) of GCP4 were used. GAPDH was used as a loading control.
(B and C) Immunofluorescence of GCP4 (green) shows lower levels in AII-1 fibroblasts than in control fibroblasts in interphase (B) and
mitosis (C).
(D) Immunofluorescence of microtubules (green) and g-tubulin (red) shows abnormal microtubule organization and altered cell
morphology in AII-1 fibroblasts. The arrow points to a binucleated cell.
(E) Immunofluorescence of lamin A/C shows nuclear defects in AII-1 fibroblasts: large nuclei, abnormal shapes, and multiple nuclei,
connected by chromatin bridges (arrow), per cell.
(F) Immunoblots of extracts from control and AII-1 fibroblasts before (input) or after fractionation in gradients of 5%–40% sucrose.
Antibodies against g-tubulin and GCP2, GCP4, GCP5, and GCP6 were used for visualizing g-TuRC components. The peak position of
the g-TuRC (fraction 7) is indicated below the figure. On the right, the quantification of g-tubulin signal intensity shows a 63% reduction
of the g-TuRC in fraction 7 from AII-1 fibroblasts.
DNA is blue in merged images. Scale bars represent 10 mm. Antibodies are anti-GCP4 Ab:Nt (R7629/30), Ab:Ct (R801),13 anti-GCP2,12
anti-g-tubulin TU-30 (Abcam), anti-GCP5 E-1 (Santa Cruz biotech.), anti-GCP6 (Abcam), anti-a-tubulin (Sigma), and anti-lamin A/C
(Santa Cruz Biotech).Immunoblotting with two different antibodies revealed
a reduction of GCP4 (gamma-tubulin complex protein 4,
encoded by TUBGCP4) levels to approximately 40% of
that in control fibroblasts (Figure 2A). No smaller GCP4
variants were detected, indicating that any potential trans-
lation products without the full complement of exons
are unstable. Reduced levels of GCP4 were confirmed
by immunofluorescence of the centrosomes, both in inter-
phase and inmitosis (Figures 2B and 2C). Further examina-
tion by immunoblot revealed that levels of all other
components (g-tubulin and GCP2, GCP5, and GCP6) of
the g-TuRC were also reduced. Moreover, we observed a
loss of more than 60% of g-TuRCs from sucrose gradients
(Figure 2F, fraction 7) in favor of smaller complexes. This670 The American Journal of Human Genetics 96, 666–674, April 2, 2was expected, given that the integrity of the g-TuRC de-
pends on proteins GCP4, GCP5, and GCP6, and lowering
the levels of any of these proteins affects the assembly of
g-TuRCs or destabilizes them.14
Consequently, cells from individual AII-1 showed
reduced levels of microtubule nucleation after depolymer-
ization in the cold (Figure S2B). We also observed that
microtubule organization was abnormal, such that micro-
tubule arrays radiating from the centrosomes were less pro-
nounced and there were fewer microtubules orienting
along the long axis of the cells (Figure 2D). This was accom-
panied by changes in cellular shape, such that affected
cells were less elongated than control cells (Figure 2D). In
mitosis, microtubule organization of the spindle apparatus015
seemed normal at first glance, although g-tubulin staining
was reduced in mutant fibroblasts (Figure S2A). However,
in interphase, we observed a 9-fold increase in nuclear
anomalies, including binucleated cells, increased nuclear
size, and abnormal nuclear shape, such as doughnut or
dumbbell shapes (2.5% in controls and 22% in mutants;
Figure 2E). These anomalies mark the presence of aneu-
ploid cells in the population of mutant fibroblasts. They
can be explained by defects occurring late in mitosis,
such as during cytokinesis (e.g., see chromatin bridge in
Figure 2E, arrow).
Next, we used the zebrafish model to elucidate the roles
of GCP4 during embryonic development. The GCP4 zebra-
fish ortholog (ENSDART00000009649) exhibits 88% iden-
tity with the human protein. In situ hybridization revealed
ubiquitous expression of tubgcp4mRNA at 48 hr post-fertil-
ization (hpf) (data not shown). A morpholino was de-
signed against the start codon of its mRNA (tubgcp4-mo,
0.9 mM) and injected into zebrafish embryos (morpholino
sequences are detailed in Table S3). Injection of tubgcp4-mo
caused 70% (n ¼ 240) of embryos to have a smaller head
and eyes, as well as a slightly shorter body axis (‘‘reduced
tail,’’ Figures 3A–3D). Eye diameter was reduced by 28%
(n ¼ 20, 56%) at 48 hpf and by 24% (n ¼ 20; 55%) at
72 hpf (Figures 3E–3G). In addition, 20% of morphants
(n ¼ 240) had a severe reduction of the body axis (dwarf
phenotype, Figure 3C). Sections through the head of the
less strongly affected embryos (Figures 3B and 3F)
confirmed the reduction of the size of the head and eyes
(Figures 3I and 3J). In contrast, only 3% of uninjected em-
bryos (n¼ 96) had a smaller head and eyes, and only 6% of
embryos injected with three different control morpholinos
(cont-mo) of unrelated genes showed these phenotypes
(n ¼ 366, data not shown). Partial rescue was obtained
by co-injection of 50 ng/ml tubgcp4-mo-resistant mRNA.
At 3 days post-fertilization (dpf), the proportion of wild-
type embryos was increased by a factor of two, and the
proportion of embryos with a ‘‘reduced tail’’ or ‘‘dwarf’’
phenotype was reduced accordingly (Figure 3H, n > 200).
The retina of morphants showed all the expected layers.
However, the retina was punctuated with rounded cells,
probably representing photoreceptors that did not mature
(Figures 3K and 3L, red arrow head). Retinal differentiation
in control embryos is basically completed at 72 hpf.15 Spe-
cific immunostaining of the double-cone photoreceptor
subtype by Zpr-1 antibody15,16 revealed a continuous, uni-
form layer of elongated photoreceptor cells in uninjected
and cont-mo-injected embryos (Figures 3M and 3O),
whereas the morphants displayed only a single patch of
immunofluorescent cones (Figure 3N). This lack of cones
was confirmed with a second morpholino directed against
the exon-intron boundary (0.9 mM; Figures S3A–S3D).
Similar to the tubgcp4-mo, the ‘‘spliced morpholino’’
caused a reduced size of the head and eyes (75% embryos,
n ¼ 200). In addition, cones as revealed by immunostain-
ing with Zpr-1 antibody developed only in a restricted
area, whereas cones covered the whole retina in controlThe Amembryos (Figure S3E; data not shown). Section through
embryos exhibiting discontinuous Zpr-1 staining revealed
the presence of a distinct layer corresponding to the photo-
receptor layer (Figure S3F). The same restricted Zpr-1 im-
munostaining was obtained at 4 and 5 dpf, excluding
the possibility that the morphants were simply develop-
mentally delayed (Figure S3G; data not shown). The
corresponding control embryos revealed a thick and well-
organized photoreceptor layer (Figures 3P, 3S, and 3U).
Next, we stained rod photoreceptors with the 1D1 anti-
body directed against rhodopsin.17 In the uninjected and
cont-mo-injected embryos, 1D1-positive cells were scat-
tered in the photoreceptor layer (Figure 3V; data not
shown), whereas no specific staining was detected in the
morphants (Figure 3W). Taken together, our results indi-
cate that the retina of morphants is composed of photore-
ceptors that have not fully differentiated. Although we
regard it as less likely, we cannot totally exclude, however,
that the rounded cells are the result of degeneration of
differentiated photoreceptors.
Inherited congenital microcephaly is a clinically and
genetically heterogeneous disorder. The biallelic TUBGCP4
mutations described herein, as well as the very recent
TUBGCP6 mutations, confirm the existence of auto-
somal-recessive cases described as MCCRP. Thus, the com-
mon hypothesis of germline mosaicism in affected siblings
with healthy parents has to be questioned. In addition,
simplex cases previously considered to involve de novo
dominant mutations could very well be linked to recessive
inheritance.1,18,19
The recent identificationsof thecausativegenetic variants
in some individuals with primary or syndromic micro-
cephaly have greatly improved our understanding of the
pathogenesis of these conditions. The disease phenotype
is associated with defects in a number of interconnected
cellular functions, including alterations of mitotic spindle
structure, of the centrosome, of ciliary function, of DNA
repair, of DNA-damage-response signaling, and of DNA
replication.20 In eukaryotic cells, the microtubule cyto-
skeleton is essential for intracellular transport, organelle
position, motility, signaling, and cell division. Assembly of
newmicrotubules relies onefficientmicrotubulenucleation
induced by the g-TuRC. The g-TuRC is a complex resulting
from the assembly ofg-tubulinwithg-tubulin complexpro-
teins GCP2, GCP3, GCP4, GCP5, and GCP6 (encoded by
TUBGCP2, TUBGCP3, TUBGCP4, TUBGCP5 [MIM 608147],
and TUBGCP6, respectively). The five GCPs share similar
core structures, although with low sequence homology.21
The TUBGCP4 mutations described herein point to the
g-TuRC, involved in microtubule organization, as a major
pathway related to syndromic microcephaly associated
with chorioretinal development abnormalities (MCCRP).
Moreover, TUBGCP6 has recently been found to be
mutated in the original MCCRP-affected family in whom
a homozygous read-through mutation was found in
affected members. However, functional investigations are
still needed to ascertain the role of the g-TuRC in theerican Journal of Human Genetics 96, 666–674, April 2, 2015 671
Figure 3. tubgcp4 Morphants Exhibit Head and Photoreceptor Developmental Anomalies in Zebrafish
(A–C) Injection of tubgcp4-mo into zebrafish embryos gave rise to dwarf embryos. (A) Uninjected embryo. (B and C) Morphants with a
mild (dwarf, B) or severe (reduced tail, C) phenotype.
(D) Charts represent the percentage of each category of phenotypes in uninjected and morphant embryos.
(E and F) Uninjected embryo (E) and tubgcp4-mo morphant (F). Same-sized circles indicate how eyes were smaller in morphant embryos
than in uninjected embryos.
(G) The chart shows the size of eyes (in pixels) of uninjected embryos and tubgcp4-mo-injected morphants.
(H) The chart shows that morphants injected with 0.9 mM of morpholino could be partially rescued with 50 ng/ml of tubgcp4-mo-
resistant mRNA (tubmRNA).
(I and J) Transverse sections through the head of uninjected embryos (I) and morphant embryos (J) revealed no obvious abnormality in
the overall morphology except that the eyes and head of the morphants were smaller.
(K and L) Higher magnification of transverse sections through the eye of a morphant reveals rounded retinal cells (K, arrowhead), which
were absent from the uninjected embryos (L).
(M–U) Zpr1 antibody staining shows a continuous, uniform layer of elongated retinal cone cells in uninjected embryos (M, P, and S) or
cont-mo-injected embryos (O and U), whereas only a restricted small patch was observed in the morphants (N, Q, R, and T). Images in
(P)–(U) are superpositions of 15 confocal images representing 24-mm thickness.
(V andW) 1D1 antibody staining shows the rhodopsin-positive rods uniformly distributed in the retina of uninjected embryos (V). This
staining was not detectable in the morphants (W).
Embryos were imaged at 48 hpf (A–G), 72 hpf (H–O, V, andW), 4 dpf (P–R), or 5 dpf (S–U). Abbreviations are as follows: L, lens; INL, inner
nuclear layer; GCL, ganglion cell layer; P, photoreceptor layer; and RPE, retinal pigment epithelium. The white arrow indicates the inner
plexiform layer, and the black arrow shows the outer plexiform layer. Scale bars represent 100 mm (I and J), 80 mm (K and L), 47 mm (M–R),
56 mm (S–U), and 23 mm (V and W).pathogenesis of the phenotype in this family.5 Very
recently, a study on families affected by growth failure,
microcephaly, and retinopathy has identified mutations
in PLK4 (MIM 605031), a master regulator of centriole
duplication, as well as mutations in its substrate TUBGCP6,
in three families,6 confirming the role of TUBGCP6 in the672 The American Journal of Human Genetics 96, 666–674, April 2, 2pathogenesis of this phenotype. CDK5RAP2 (MIM 608201)
and CENPJ (MIM 609279) have been found to be mutated
in individuals with autosomal-recessive primary non-syn-
dromic microcephaly and to encode centrosomal proteins
that interact with the g-TuRC.22,23 Interestingly, severe
microcephaly with malformation of cortical development015
has been reported in individuals with mutations in TUBG1
(MIM 191135), one of two human genes encoding
g-tubulin.24 Defects in a- and b-tubulin and in microtu-
bule-interacting proteins (i.e., encoded by KIF2A [MIM
602591] and KIF5C [MIM 604593]) have been reported in
microcephaly associated with marked cortical develop-
mental anomalies—such as pachygyria, polymicrogyria,
or lissencephaly—manifesting with epilepsy and profound
cognitive impairment.24 In contrast, the microcephaly-
affected individuals reported to have chorioretinal
dysplasia, related to microtubule-interacting proteins,
such as those encoded by KIF11, TUBGCP6, and TUBGCP4
(reported here), have not been reported to have any major
cerebral malformation. However, epilepsy was reported
in 8% of MCLMR with KIF11 mutations, and learning
difficulties of varying degrees are very common (73% of
affected individuals).25 It would be conceivable that such
GCP4-dependent defects might lead to developmental
abnormalities in the neocortex and therefore result in
reduced brain growth. The compound-heterozygous muta-
tions identified in family A do not lead to total absence of
GCP4. It is likely that such total absence would be lethal in
the embryo. Our hypothesis is that the synonymous muta-
tion, identified in three families, impairs splicing and thus
leads to reduced amounts of functional GCP4.
We have demonstrated the impact of the TUBGCP4
mutations on cell morphology in cells from an affected in-
dividual (AII-1). Our findings are consistent with previous
reports documenting that reduced amounts of GCP4 led
to downregulation of other GCPs and to reduced amounts
of the g-TuRC.14,26 Consequently, microtubule nucleation
was reduced in fibroblasts from affected individuals.
Although it has been shown in organisms such as
Drosophila that loss of GCP4 orthologs does not prevent
the formation of mitotic spindles, subtle defects in mitosis,
including altered spindle morphology and defects in spin-
dle orientation, have nevertheless been observed.14,27
Moreover, neuroblasts from mutant Drosophila larvae
exhibited delayed mitosis and low frequencies of aneu-
ploidy.14 We also detected aneuploidy in the affected
individual’s fibroblasts, marked by the presence of binucle-
ated cells or nuclei of increased size.
The zebrafish model has been proven to be an efficient
model for investigating the role of previously reported
genes (namely STIL, ASPM, WDR62, and ODF2) in human
microcephaly, given that the phenotype in zebrafish re-
sults in a marked reduction in head and eye size.28 More-
over, microcephaly models in the developing zebrafish
have pointed to an underlying defect in metaphase pro-
gression in the retinal neuroepithelium.28 The tubgcp4 ze-
brafish model described herein reproduces head anomalies
and interestingly demonstrates clustered abnormalities
in photoreceptor development, pointing to a common
developmental denominator for rods and cones. The
human-specific ocular phenotype shows major chorioreti-
nal developmental abnormalities, ranging from atrophic
punched-out retinal lesions surrounded by zones with ab-The Amsent retinal vasculature to retinal folds (a typical stigmata
of early-onset abnormality of retinal vascular develop-
ment). One hypothesis would be that the zones in which
the clusters of abnormal photoreceptor cells exist have
altered development of other retinal layers, explaining
this punched-out appearance.
In summary, because KIF11, TUBGCP6, and TUBGCP4
are all implicated in both dominant and recessive forms
of microcephaly with chorioretinal dysplasia, this com-
mon pathway in the critical stages of brain and retinal
development warrants further investigations and has im-
plications for the genetic counselling of MCCRP-affected
individuals.Supplemental Data
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ajhg.2015.02.011.Acknowledgments
We wish to warmly thank the individuals and their families for
their participation. We would like to thank Jean-Louis Mandel
and the financial support of the Centre Re´gional de Ge´ne´tique
Me´dicale de Strasbourg, Caisse d’Assurance Retraite et de la Sante´
au Travail Alsace-Moselle, and RETINA France. Sequencing was
performed by the IGBMC Microarray and Sequencing platform,
a member of the ‘‘France Ge´nomique’’ consortium (ANR-10-
INBS-0009). This workwas funded in part by the National Institute
for Health Research and Biomedical Research Centre at Moorfields
Eye Hospital and the UCL Institute of Ophthalmology (London),
Fight For Sight (London), Rosetrees Trust (Edgware), and the
Agence Nationale de la Recherche (L.H. and A.M.). We are grateful
for support from the European Commission through IP ZF-Health
(FP7-HEALTH-2007-B2) and the Interreg Network for Synthetic
Biology in the Upper Rhine valley (NSB-Upper Rhine, C.E. and
U.S.). This work was approved by local ethics committees at Moor-
fields Eye Hospital, Hoˆpitaux Universitaires de Strasbourg (Stras-
bourg University Hospital), and Robert Debre´ Hospital.
Received: November 16, 2014
Accepted: February 19, 2015
Published: March 26, 2015Web Resources
The URLs for data presented herein are as follows:
ANNOVAR, http://www.openbioinformatics.org/
dbSNP, http://www.ncbi.nlm.nih.gov/projects/SNP/
ExAC Browser, http://exac.broadinstitute.org/
NHLBI Exome Sequencing Project (ESP) Exome Variant Server,
http://evs.gs.washington.edu/EVS/
OMIM, http://www.omim.org/
Orphanet, http://www.orpha.net/
PolyPhen-2, http://www.genetics.bwh.harvard.edu/pph2/
RefSeq, http://www.ncbi.nlm.nih.gov/refseq/
SIFT, http://sift.bii.a-star.edu.sg/
VaRank, http://www.lbgi.fr/VaRank
UCSC Genome Browser, http://genome.ucsc.eduerican Journal of Human Genetics 96, 666–674, April 2, 2015 673
References
1. Alzial, C., Dufier, J.L., Brasnu, C., Aicardi, J., and de Grouchy, J.
(1980). [‘‘True’’ microcephaly with dominant-inheritance cho-
rioretinal dysplasia]. Ann. Genet. 23, 91–94.
2. Ostergaard, P., Simpson, M.A., Mendola, A., Vasudevan, P.,
Connell, F.C., van Impel, A., Moore, A.T., Loeys, B.L., Ghalam-
karpour, A., Onoufriadis, A., et al. (2012). Mutations in KIF11
cause autosomal-dominant microcephaly variably associated
with congenital lymphedema and chorioretinopathy. Am. J.
Hum. Genet. 90, 356–362.
3. McKusick, V.A., Stauffer, M., Knox, D.L., and Clark, D.B.
(1966). Chorioretinopathy with hereditary microcephaly.
Arch. Ophthalmol. 75, 597–600.
4. Nguyen, T.N., Der Kaloustian, V.M., Barsoum-Homsy, M.,
Dembinska, O., and Koenekoop, R.K. (2005). Congenital
microcephaly, juvenile retinal dystrophy and normal menta-
tion in a mildly dysmorphic child. Can. J. Ophthalmol. 40,
195–199.
5. Puffenberger, E.G., Jinks, R.N., Sougnez, C., Cibulskis, K., Wil-
lert, R.A., Achilly, N.P., Cassidy, R.P., Fiorentini, C.J., Heiken,
K.F., Lawrence, J.J., et al. (2012). Genetic mapping and exome
sequencing identify variants associated with five novel dis-
eases. PLoS ONE 7, e28936.
6. Martin, C.A., Ahmad, I., Klingseisen, A., Hussain, M.S., Bick-
nell, L.S., Leitch, A., Nu¨rnberg, G., Toliat, M.R., Murray, J.E.,
Hunt, D., et al. (2014). Mutations in PLK4, encoding a master
regulator of centriole biogenesis, cause microcephaly, growth
failure and retinopathy. Nat. Genet. 46, 1283–1292.
7. Kumar, P., Henikoff, S., and Ng, P.C. (2009). Predicting the ef-
fects of coding non-synonymous variants on protein function
using the SIFT algorithm. Nat. Protoc. 4, 1073–1081.
8. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E.,
Gerasimova, A., Bork, P., Kondrashov, A.S., and Sunyaev, S.R.
(2010). A method and server for predicting damaging
missense mutations. Nat. Methods 7, 248–249.
9. Yamamoto, S., Shimizu, S., Kiyonaka, S., Takahashi, N.,
Wajima, T., Hara, Y., Negoro, T., Hiroi, T., Kiuchi, Y., Okada,
T., et al. (2008). TRPM2-mediated Ca2þinflux induces chemo-
kine production in monocytes that aggravates inflammatory
neutrophil infiltration. Nat. Med. 14, 738–747.
10. Wang, K., Li, M., and Hakonarson, H. (2010). ANNOVAR:
functional annotation of genetic variants from high-
throughput sequencing data. Nucleic Acids Res. 38, e164.
11. Plagnol, V., Curtis, J., Epstein, M., Mok, K.Y., Stebbings, E.,
Grigoriadou, S., Wood, N.W., Hambleton, S., Burns, S.O.,
Thrasher, A.J., et al. (2012). A robust model for read count
data in exome sequencing experiments and implications for
copy number variant calling. Bioinformatics 28, 2747–2754.
12. Haren, L., Remy, M.H., Bazin, I., Callebaut, I., Wright, M., and
Merdes, A. (2006). NEDD1-dependent recruitment of the
gamma-tubulin ring complex to the centrosome is necessary
for centriole duplication and spindle assembly. J. Cell Biol.
172, 505–515.
13. Fava, F., Raynaud-Messina, B., Leung-Tack, J., Mazzolini, L., Li,
M., Guillemot, J.C., Cachot, D., Tollon, Y., Ferrara, P., and
Wright, M. (1999). Human 76p: A newmember of the gamma-
tubulin-associated protein family. J. Cell Biol. 147, 857–868.
14. Ve´rollet, C., Colombie´, N., Daubon, T., Bourbon, H.M.,
Wright, M., and Raynaud-Messina, B. (2006). Drosophila mel-
anogaster gamma-TuRC is dispensable for targeting gamma-674 The American Journal of Human Genetics 96, 666–674, April 2, 2tubulin to the centrosome and microtubule nucleation.
J. Cell Biol. 172, 517–528.
15. Raymond, P.A., Barthel, L.K., and Curran, G.A. (1995). Devel-
opmental patterning of rod and cone photoreceptors in
embryonic zebrafish. J. Comp. Neurol. 359, 537–550.
16. Biehlmaier, O., Lampert, J.M., von Lintig, J., and Kohler, K.
(2005). Photoreceptor morphology is severely affected in the
beta,beta-carotene-15,150-oxygenase (bcox) zebrafish mor-
phant. Eur. J. Neurosci. 21, 59–68.
17. Morris, A.C., and Fadool, J.M. (2005). Studying rod photore-
ceptor development in zebrafish. Physiol. Behav. 86, 306–313.
18. Jarmas, A.L., Weaver, D.D., Ellis, F.D., and Davis, A. (1981).
Microcephaly, microphthalmia, falciform retinal folds, and
blindness. A new syndrome. Am. J. Dis. Child. 135, 930–933.
19. Trzupek, K.M., Falk, R.E., Demer, J.L., and Weleber, R.G.
(2007). Microcephaly with chorioretinopathy in a brother-sis-
ter pair: evidence for germ linemosaicism and further delinea-
tion of the ocular phenotype. Am. J. Med. Genet. A. 143A,
1218–1222.
20. Alcantara, D., and O’Driscoll, M. (2014). Congenital micro-
cephaly. Am. J. Med. Genet. C. Semin. Med. Genet. 166C,
124–139.
21. Guillet, V., Knibiehler, M., Gregory-Pauron, L., Remy, M.H.,
Chemin, C., Raynaud-Messina, B., Bon, C., Kollman, J.M.,
Agard, D.A., Merdes, A., and Mourey, L. (2011). Crystal struc-
ture of g-tubulin complex protein GCP4 provides insight into
microtubule nucleation. Nat. Struct. Mol. Biol. 18, 915–919.
22. Bond, J., Roberts, E., Springell, K., Lizarraga, S.B., Scott, S., Hig-
gins, J., Hampshire, D.J., Morrison, E.E., Leal, G.F., Silva, E.O.,
et al. (2005). A centrosomal mechanism involving CDK5RAP2
and CENPJ controls brain size. Nat. Genet. 37, 353–355.
23. Issa, L., Mueller, K., Seufert, K., Kraemer, N., Rosenkotter, H.,
Ninnemann, O., Buob, M., Kaindl, A.M., and Morris-Rose-
ndahl, D.J. (2013). Clinical and cellular features in patients
with primary autosomal recessive microcephaly and a novel
CDK5RAP2 mutation. Orphanet J. Rare Dis. 8, 59.
24. Poirier, K., Lebrun, N., Broix, L., Tian, G., Saillour, Y.,
Boscheron, C., Parrini, E., Valence, S., Pierre, B.S., Oger, M.,
et al. (2013). Mutations in TUBG1, DYNC1H1, KIF5C and
KIF2A cause malformations of cortical development and
microcephaly. Nat. Genet. 45, 639–647.
25. Jones, G.E., Ostergaard, P., Moore, A.T., Connell, F.C.,
Williams, D., Quarrell, O., Brady, A.F., Spier, I., Hazan, F.,
Moldovan, O., et al. (2014). Microcephaly with or without
chorioretinopathy, lymphoedema, or mental retardation
(MCLMR): review of phenotype associated with KIF11 muta-
tions. Eur. J. Hum. Genet. 22, 881–887.
26. Bouissou, A., Ve´rollet, C., Sousa, A., Sampaio, P., Wright, M.,
Sunkel, C.E., Merdes, A., and Raynaud-Messina, B. (2009).
gamma-Tubulin ring complexes regulate microtubule plus
end dynamics. J. Cell Biol. 187, 327–334.
27. Bouissou, A., Ve´rollet, C., de Forges, H., Haren, L., Bellaı¨che, Y.,
Perez, F., Merdes, A., and Raynaud-Messina, B. (2014).
g-Tubulin Ring Complexes and EB1 play antagonistic roles
in microtubule dynamics and spindle positioning. EMBO J.
33, 114–128.
28. Novorol, C., Burkhardt, J., Wood, K.J., Iqbal, A., Roque, C.,
Coutts, N., Almeida, A.D., He, J., Wilkinson, C.J., and Harris,
W.A. (2013). Microcephalymodels in the developing zebrafish
retinal neuroepithelium point to an underlying defect in
metaphase progression. Open Biol. 3, 130065.015
